Correlates of HIV vaccine trial participation: An Indian perspective

Seema Sahay, Sanjay Mehendale, Suvarna Sane, Radhika Brahme, Amishah Brown, Karen Charron, Christopher Beyrer, Robert C Bollinger, Ramesh Paranjape

Research output: Contribution to journalArticle

Abstract

Successful conduct of HIV vaccine trials in a population of great cultural diversity like India could be a challenge. Concerns, knowledge gaps and willingness to participate in future HIV vaccine trials were studied among 349 patients attending three sexually transmitted infections clinics and one reproductive tract infections clinic. Overall willingness to volunteer for HIV vaccine trials was 48%. Women and men at risk of HIV infection were willing to participate in the HIV vaccine trials. Factors associated with increased willingness to participate in these trials were awareness of current HIV vaccine efforts, realization of importance of vaccine for self, concern about adverse events and altruism.

Original languageEnglish (US)
Pages (from-to)1351-1358
Number of pages8
JournalVaccine
Volume23
Issue number11
DOIs
StatePublished - Feb 3 2005

Fingerprint

AIDS Vaccines
vaccines
Reproductive Tract Infections
Altruism
Cultural Diversity
sexually transmitted diseases
multicultural diversity
Sexually Transmitted Diseases
altruism
HIV infections
HIV Infections
India
Volunteers
Vaccines
volunteers
Population
infection

Keywords

  • HIV vaccine
  • Trial
  • Willingness

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Sahay, S., Mehendale, S., Sane, S., Brahme, R., Brown, A., Charron, K., ... Paranjape, R. (2005). Correlates of HIV vaccine trial participation: An Indian perspective. Vaccine, 23(11), 1351-1358. https://doi.org/10.1016/j.vaccine.2004.09.032

Correlates of HIV vaccine trial participation : An Indian perspective. / Sahay, Seema; Mehendale, Sanjay; Sane, Suvarna; Brahme, Radhika; Brown, Amishah; Charron, Karen; Beyrer, Christopher; Bollinger, Robert C; Paranjape, Ramesh.

In: Vaccine, Vol. 23, No. 11, 03.02.2005, p. 1351-1358.

Research output: Contribution to journalArticle

Sahay, S, Mehendale, S, Sane, S, Brahme, R, Brown, A, Charron, K, Beyrer, C, Bollinger, RC & Paranjape, R 2005, 'Correlates of HIV vaccine trial participation: An Indian perspective', Vaccine, vol. 23, no. 11, pp. 1351-1358. https://doi.org/10.1016/j.vaccine.2004.09.032
Sahay S, Mehendale S, Sane S, Brahme R, Brown A, Charron K et al. Correlates of HIV vaccine trial participation: An Indian perspective. Vaccine. 2005 Feb 3;23(11):1351-1358. https://doi.org/10.1016/j.vaccine.2004.09.032
Sahay, Seema ; Mehendale, Sanjay ; Sane, Suvarna ; Brahme, Radhika ; Brown, Amishah ; Charron, Karen ; Beyrer, Christopher ; Bollinger, Robert C ; Paranjape, Ramesh. / Correlates of HIV vaccine trial participation : An Indian perspective. In: Vaccine. 2005 ; Vol. 23, No. 11. pp. 1351-1358.
@article{916f7f6cd44c4bc79a6812d3bd3146a1,
title = "Correlates of HIV vaccine trial participation: An Indian perspective",
abstract = "Successful conduct of HIV vaccine trials in a population of great cultural diversity like India could be a challenge. Concerns, knowledge gaps and willingness to participate in future HIV vaccine trials were studied among 349 patients attending three sexually transmitted infections clinics and one reproductive tract infections clinic. Overall willingness to volunteer for HIV vaccine trials was 48{\%}. Women and men at risk of HIV infection were willing to participate in the HIV vaccine trials. Factors associated with increased willingness to participate in these trials were awareness of current HIV vaccine efforts, realization of importance of vaccine for self, concern about adverse events and altruism.",
keywords = "HIV vaccine, Trial, Willingness",
author = "Seema Sahay and Sanjay Mehendale and Suvarna Sane and Radhika Brahme and Amishah Brown and Karen Charron and Christopher Beyrer and Bollinger, {Robert C} and Ramesh Paranjape",
year = "2005",
month = "2",
day = "3",
doi = "10.1016/j.vaccine.2004.09.032",
language = "English (US)",
volume = "23",
pages = "1351--1358",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "11",

}

TY - JOUR

T1 - Correlates of HIV vaccine trial participation

T2 - An Indian perspective

AU - Sahay, Seema

AU - Mehendale, Sanjay

AU - Sane, Suvarna

AU - Brahme, Radhika

AU - Brown, Amishah

AU - Charron, Karen

AU - Beyrer, Christopher

AU - Bollinger, Robert C

AU - Paranjape, Ramesh

PY - 2005/2/3

Y1 - 2005/2/3

N2 - Successful conduct of HIV vaccine trials in a population of great cultural diversity like India could be a challenge. Concerns, knowledge gaps and willingness to participate in future HIV vaccine trials were studied among 349 patients attending three sexually transmitted infections clinics and one reproductive tract infections clinic. Overall willingness to volunteer for HIV vaccine trials was 48%. Women and men at risk of HIV infection were willing to participate in the HIV vaccine trials. Factors associated with increased willingness to participate in these trials were awareness of current HIV vaccine efforts, realization of importance of vaccine for self, concern about adverse events and altruism.

AB - Successful conduct of HIV vaccine trials in a population of great cultural diversity like India could be a challenge. Concerns, knowledge gaps and willingness to participate in future HIV vaccine trials were studied among 349 patients attending three sexually transmitted infections clinics and one reproductive tract infections clinic. Overall willingness to volunteer for HIV vaccine trials was 48%. Women and men at risk of HIV infection were willing to participate in the HIV vaccine trials. Factors associated with increased willingness to participate in these trials were awareness of current HIV vaccine efforts, realization of importance of vaccine for self, concern about adverse events and altruism.

KW - HIV vaccine

KW - Trial

KW - Willingness

UR - http://www.scopus.com/inward/record.url?scp=12344298142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12344298142&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2004.09.032

DO - 10.1016/j.vaccine.2004.09.032

M3 - Article

C2 - 15661383

AN - SCOPUS:12344298142

VL - 23

SP - 1351

EP - 1358

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 11

ER -